Petrus Jarvinen

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Oncological Results After Accidental Tumor Incision During Partial Nephrectomy.

Oncological Results After Accidental Tumor Incision During Partial Nephrectomy.

Journal: European urology open science
Published: November 05, 2025

Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Journal: Cancer research communications
Published: August 01, 2025

A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial.

A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial.

Journal: European urology
Published: June 29, 2025

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Journal: Theranostics
Published: May 28, 2025

Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses.

Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses.

Journal: Oncoimmunology
Published: February 17, 2025

Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.

Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.

Journal: European urology oncology
Published: December 23, 2024

Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial.

Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial.

Journal: The Journal of infection
Published: February 19, 2024

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.

Journal: Cancer medicine
Published: October 30, 2023

Practice Variation in the Management of Adult Hydroceles: A Multinational Survey.

Practice Variation in the Management of Adult Hydroceles: A Multinational Survey.

Journal: European urology open science
Published: September 14, 2023

Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.

Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.

Journal: Cancer research communications
Published: December 19, 2022

Risk of Complications After Hydrocele Surgery: A Retrospective Multicenter Study in Helsinki Metropolitan Area.

Risk of Complications After Hydrocele Surgery: A Retrospective Multicenter Study in Helsinki Metropolitan Area.

Journal: European urology open science
Published: June 17, 2022

Recurrence pattern in localized RCC: results from a European multicenter database (RECUR).

Recurrence pattern in localized RCC: results from a European multicenter database (RECUR).

Journal: Urologic oncology
Published: March 20, 2022
Showing 1-12 of 43

Last Updated: 09/26/2026